1. Home
  2. PMCB vs ZBAI Comparison

PMCB vs ZBAI Comparison

Compare PMCB & ZBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • ZBAI
  • Stock Information
  • Founded
  • PMCB 1996
  • ZBAI 2015
  • Country
  • PMCB United States
  • ZBAI United States
  • Employees
  • PMCB N/A
  • ZBAI N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • ZBAI Professional Services
  • Sector
  • PMCB Health Care
  • ZBAI Consumer Discretionary
  • Exchange
  • PMCB Nasdaq
  • ZBAI Nasdaq
  • Market Cap
  • PMCB 5.8M
  • ZBAI 6.5M
  • IPO Year
  • PMCB N/A
  • ZBAI N/A
  • Fundamental
  • Price
  • PMCB $0.90
  • ZBAI $5.75
  • Analyst Decision
  • PMCB
  • ZBAI
  • Analyst Count
  • PMCB 0
  • ZBAI 0
  • Target Price
  • PMCB N/A
  • ZBAI N/A
  • AVG Volume (30 Days)
  • PMCB 38.8K
  • ZBAI 35.0K
  • Earning Date
  • PMCB 08-11-2025
  • ZBAI 06-06-2025
  • Dividend Yield
  • PMCB N/A
  • ZBAI N/A
  • EPS Growth
  • PMCB N/A
  • ZBAI N/A
  • EPS
  • PMCB 3.19
  • ZBAI N/A
  • Revenue
  • PMCB N/A
  • ZBAI $720,000.00
  • Revenue This Year
  • PMCB N/A
  • ZBAI N/A
  • Revenue Next Year
  • PMCB N/A
  • ZBAI N/A
  • P/E Ratio
  • PMCB $0.28
  • ZBAI N/A
  • Revenue Growth
  • PMCB N/A
  • ZBAI 44.00
  • 52 Week Low
  • PMCB $0.80
  • ZBAI $4.93
  • 52 Week High
  • PMCB $2.42
  • ZBAI $45.00
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 41.85
  • ZBAI N/A
  • Support Level
  • PMCB $0.84
  • ZBAI N/A
  • Resistance Level
  • PMCB $0.95
  • ZBAI N/A
  • Average True Range (ATR)
  • PMCB 0.07
  • ZBAI 0.00
  • MACD
  • PMCB -0.00
  • ZBAI 0.00
  • Stochastic Oscillator
  • PMCB 39.96
  • ZBAI 0.00

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About ZBAI ATIF Holdings Limited Ordinary Shares

ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.

Share on Social Networks: